What's inside this report?

• This report is an essential source for in-depth information and data relating to Country "Sector" industry . It also offers detailed and comprehensive coverage of industry revenue, volume, distribution and industry player share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the "Sector"in Country.

Scope of the Research

• The report provides segment information broken down into detailed categories and sectors in country.
• Total revenues, products sold, end users, and average pricing.
• Industry shares of all the key competitors.
• Key pipeline products that are set to shape the industry , broken down by segment .
• Information on the top medical equipment industry players in the segment in the country covering business description, strategic analysis, and financial information.
• Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
• Product and brand updates, strategy changes, Research and Development projects , corporate growths and contractions and regulation modifications .
• Key M&A deals , partnerships, private equity investments and IPOs.
• Customer, hospitals and physicians data.

Reasons to buy

• Gain a strong understanding of the market at a global level, with break downs for the country
• Evaluate and compare the attractiveness of the industry in the country.
• Identify growth sectors and opportunities in each market segment within the country.
• Evaluate the pipeline of key products that will change the segment , and identify threats and opportunities before the products are launched in the country.
• Analyze the competitiveness of the industry in the country and identify hotspots.
• Develop strategies based on the latest product, brand, expansion and research and development news in the country.
• Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the industry in the country.
• Identify and analyze the strengths and weaknesses of the market incumbents in the country.

Table Of Contents

Sector in Country Report
Table of Contents
1 Table Of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Definitions
2.2.1 Cardiovascular Devices
3 Healthcare Segment Review
3.1 Healthcare Expenditure
3.2 Healthcare Infrastructure
3.2.1 Healthcare Personnel Data
3.2.2 Healthcare Facilities Data
3.3 Healthcare Policy
4 Cardiovascular Devices in France
4.1 Cardiovascular Devices Overall Revenues (from 2000 to 2012 )
4.2 Cardiovascular Devices Overall Volume (from 2000 to 2012 )
4.3 Cardiovascular Devices Overall Firms Share (2005-2006)
5 Cardiac Rhythm Management in France
5.1 Cardiac Rhythm Management Overall Revenue (from 2000 to 2012 )
5.1.1 Defibrillator Overall Revenues (from 2000 to 2012 )
5.1.2 Pacemaker Overall Revenues (from 2000 to 2012 )
5.1.3 Cardiovascular Leads and Lead System Overall Revenues (from 2000 to 2012 )
5.2 Cardiac Rhythm Management Overall Volumes (from 2000 to 2012 )
5.2.1 Cardiovascular leads and lead System Overall Volume (from 2000 to 2012 )
5.2.2 Pacemaker Overall Volume (from 2000 to 2012 )
5.2.3 Defibrillator Overall Volume (from 2000 to 2012 )
5.3 Cardiac Rhythm Management Average Price (from 2000 to 2012 )
5.3.1 Pacemaker Average Price (from 2000 to 2012 )
5.3.2 Defibrillator Average Price (from 2000 to 2012 )
5.3.3 Cardiovascular Leads and Lead System Average Price (from 2000 to 2012 )
5.4 Cardiac Rhythm Management Distribution Share (2005-2006)
5.5 Cardiac Rhythm Management Firms Share (2005-2006)
6 Interventional Cardiology in France
6.1 Interventional Cardiology Overall Revenues (from 2000 to 2012 )
6.1.1 Coronary Stent Overall Revenues (from 2000 to 2012 )
6.1.2 PTCA Balloon Overall Revenues (from 2000 to 2012 )
6.1.3 Cardiac Catheter Overall Revenues (from 2000 to 2012 )
6.2 Interventional Cardiology Overall Volumes (from 2000 to 2012 )
6.2.1 Cardiac Catheter Overall Volumes (from 2000 to 2012 )
6.2.2 Coronary Stents Overall Volume (from 2000 to 2012 )
6.2.3 PTCA Balloon Overall Volumes (from 2000 to 2012 )
6.3 Interventional Cardiology Average Price (from 2000 to 2012 )
6.3.1 Coronary stents Average Price (from 2000 to 2012 )
6.3.2 Cardiac Catheter Average price (from 2000 to 2012 )
6.3.3 PTCA Balloon Average Price (from 2000 to 2012 )
6.4 Interventional Cardiology Distribution Share (2005-2006)
6.5 Interventional Cardiology Firms Share (2005-2006)
7 Cardiovascular Surgery in France
7.1 Cardiovascular Surgery Overall Revenues (from 2000 to 2012 )
7.1.1 Perfusion System Overall Revenues (from 2000 to 2012 )
7.1.2 Cardiac Ablation Device Overall Revenues (from 2000 to 2012 )
7.1.3 Beating Heart Surgery System Overall Revenues (from 2000 to 2012
7.2 Cardiovascular Surgery Overall Volume (from 2000 to 2012 )
7.2.1 Beating Heart Surgery System Overall Volume (from 2000 to 2012 )
7.2.2 Cardiac Ablation Device Overall Volume (from 2000 to 2012 )
7.2.3 Perfusion System Overall Volume (from 2000 to 2012 )
7.3 Cardiovascular Surgery Average Price (from 2000 to 2012 )
7.3.1 Beating Heart Surgery System Average Price (from 2000 to 2012 )
7.3.2 Cardiac Ablation Device Average Price (from 2000 to 2012 )
7.3.3 Perfusion System Average Price (from 2000 to 2012 )
7.4 Cardiovascular Surgery Distribution Share (from 2000 to 2012 )
7.5 Cardiovascular Surgery Firms Share (from 2000 to 2012 )
8 Peripheral Vascular Devices in France
8.1 Peripheral Vascular Devices Overall Revenue (from 2000 to 2012 )
8.1.1 Peripheral Vascular Stent Overall Revenues (from 2000 to 2012 )
8.1.2 PTA Balloon Overall Revenues (from 2000 to 2012 )
8.1.3 Arotic Stent Graft March ket Overall Revenues (from 2000 to 2012 )
8.1.4 Inferior Vena Cava Filter Overall Revenues (from 2000 to 2012 )
8.2 Peripheral Vascular Devices Overall Volume (from 2000 to 2012 )
8.2.1 Peripheral Vascular Stent Overall Volume (from 2000 to 2012 )
8.2.2 PTA Balloon Overall Volume (from 2000 to 2012 )
8.2.3 Inferior Vena Cava Filter Overall Volume (from 2000 to 2012 )
8.2.4 Arotic Stent Graft March ket Overall Volume (from 2000 to 2012 )
8.3 Peripheral Vascular Devices Average Price (from 2000 to 2012 )
8.3.1 Peripheral Vascular Stents Average Price (from 2000 to 2012 )
8.3.2 Inferior Vena Cava Filter Average Price (from 2000 to 2012 )
8.3.3 PTA Balloon Average Price (from 2000 to 2012 )
8.3.4 Arotic Stent Graft March ket Average Price (from 2000 to 2012 )
8.4 Peripheral Vascular Devices Distribution Share (2005-2006)
8.5 Peripheral Vascular Devices Firms Share (2005-2006)
9 Cardiovascular Prosthetic Devices in France
9.1 Cardiovascular Prosthetic Devices Overall Revenue (from 2000 to 2012 )
9.1.1 Prosthetic Heart Valve Overall Revenues (from 2000 to 2012 )
9.1.2 Cardiac Assist Device Overall Revenues (from 2000 to 2012 )
9.2 Cardiovascular Prosthetic Devices Overall Volume (from 2000 to 2012 )
9.2.1 Prosthetic Heart Valve Overall Volume (from 2000 to 2012 )
9.2.2 Cardiac Assist Device Overall Volume (from 2000 to 2012 )
9.3 Cardiovascular Prosthetic Devices Average Price (from 2000 to 2012 )
9.3.1 Prosthetic Heart Valve Average Price (from 2000 to 2012 )
9.3.2 Cardiac Assist Devices Average Price (from 2000 to 2012 )
9.4 Cardiovascular Prosthetic Devices Distribution Share (2005-2006)
9.5 Cardiovascular Prosthetic Devices Firms Share (2005-2006)
10 Cardiovascular Monitoring and Diagnostic Devices in France
10.1 Cardiovascular Monitoring and Diagnostic Devices Overall Revenue (from 2000 to 2012 )
10.2 Cardiovascular Monitoring and Diagnostic Devices Overall Volume (from 2000 to 2012 )
10.2.1 ECG Monitoring Equipment Overall Volume (from 2000 to 2012 )
10.2.2 Holter Monitoring System Overall Volume (from 2000 to 2012 )
10.2.3 Event Monitoring System Overall Volume (from 2000 to 2012 )
10.2.4 ECG Stress Testing System Overall Volume (from 2000 to 2012 )
10.3 Cardiovascular Monitoring and Diagnostic Devices Average Price (2005-2006)
10.3.1 ECG Monitoring Equipment Average Price (from 2000 to 2012 )
10.3.2 ECG Stress Testing System Average Price (from 2000 to 2012 )
10.3.3 Holter Monitoring System Average Price (from 2000 to 2012 )
10.3.4 Event Monitoring System Average Price (from 2000 to 2012 )
10.4 Cardiovascular Monitoring and Diagnostic Devices Distribution Share (2005-2006)
10.5 Cardiovascular Monitoring and Diagnostic Devices Firms Share (2005-2006)
11 Regulation System
11.1 Medical Equipment Approval
11.2 Central Drugs Authority of France (CDAI)
11.3 Medical Device Regulatory Authority of France (MDRAI)
11.4 Classification of medical devices
11.4.1 Registration Period
12 Pricing and Reimbursement
13 Distribution Structure
14 APPENDIX
14.1 Methodology
14.2 Currency Conversion
14.3 Contact Us
14.4 Disclaimer
Note: Some content types may not be available in this report

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

2014 Market Segmentation Analysis of the Global Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations

2014 Market Segmentation Analysis of the Global Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations

  • $ 34 500
  • Industry report
  • July 2014
  • by Venture Planning Group

Complete report $34,500.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

Emerging Opportunities in the Global Virology and Bacteriology Testing Market

Emerging Opportunities in the Global Virology and Bacteriology Testing Market

  • $ 21 100
  • Industry report
  • June 2014
  • by Venture Planning Group

“Emerging Opportunities in the Global Virology and Bacteriology Testing Market” is a new seven-country strategic analysis of major business opportunities emerging in the infectious disease testing ...

Future Horizons and Growth Strategies in the Global Microbiology Testing Market 2014: Supplier Shares and Country Forecasts

Future Horizons and Growth Strategies in the Global Microbiology Testing Market 2014: Supplier Shares and Country Forecasts

  • $ 21 100
  • Industry report
  • August 2014
  • by Venture Planning Group

Complete report $32,500.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. “2014 Strategies for the Global Microbiology Testing Market” is a new seven-country strategic analysis ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.